Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Morrisette

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Infectious Diseases and Therapy|February 24, 2020
Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-AvibactamSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2020
Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial InfectionsSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
Open Forum Infectious Diseases|February 25, 2021
Preliminary, Real-world, Multicenter Experience With Omadacycline for <i>Mycobacterium abscessus</i> InfectionsTaylor Morrisette, Sara Alosaimy, Julie V Philley, et al.
Open Forum Infectious Diseases|January 1, 2020
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial InfectionsSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2023
Phage-antibiotic combinations against multidrug-resistant <i>Pseudomonas aeruginosa</i> in <i>in vitro</i> static and dynamic biofilm modelsDana J Holger, Amer El Ghali, Natasha Bhutani, et al.
Open Forum Infectious Diseases|July 14, 2021
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia: STAPH StudySara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Open Forum Infectious Diseases|December 13, 2021
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative InfectionsNicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, et al.
BMC Infectious Diseases|May 26, 2026
Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infectionsMohammed Al Musawa, Amer El Ghali, Taylor Morrisette, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|April 22, 2026
Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative InfectionsTaylor Morrisette, Grant T Stimes, Gustavo R Alvira-Arill, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Infectious Diseases and Therapy|February 24, 2020
Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-AvibactamSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2020
Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial InfectionsSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
Open Forum Infectious Diseases|February 25, 2021
Preliminary, Real-world, Multicenter Experience With Omadacycline for <i>Mycobacterium abscessus</i> InfectionsTaylor Morrisette, Sara Alosaimy, Julie V Philley, et al.
Open Forum Infectious Diseases|January 1, 2020
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial InfectionsSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2023
Phage-antibiotic combinations against multidrug-resistant <i>Pseudomonas aeruginosa</i> in <i>in vitro</i> static and dynamic biofilm modelsDana J Holger, Amer El Ghali, Natasha Bhutani, et al.
Open Forum Infectious Diseases|July 14, 2021
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia: STAPH StudySara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Open Forum Infectious Diseases|December 13, 2021
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative InfectionsNicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, et al.
BMC Infectious Diseases|May 26, 2026
Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infectionsMohammed Al Musawa, Amer El Ghali, Taylor Morrisette, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|April 22, 2026
Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative InfectionsTaylor Morrisette, Grant T Stimes, Gustavo R Alvira-Arill, et al.
Pageof 8